Bruno Carlos
Sangro Gómez-Acebo

Catedrático de Universidad

Foto de Bruno Carlos

Foto de Idoia

Idoia
Bilbao Del Olmo

Colaboradora Clínica

Publicacións nas que colabora con Idoia Bilbao Del Olmo (6)

2024

Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190

2022

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
Cancer Imaging, Vol. 22, Núm. 1

2021

Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage
Hepatology, Vol. 74, Núm. 5, pp. 2791-2807

2018

Pneumatocele during sorafenib therapy: First report of an unusual complication
Oncotarget, Vol. 9, Núm. 5, pp. 6652-6656

2015

Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: Analysis of the European multicentre trial SORAMIC
Liver International, Vol. 35, Núm. 2, pp. 620-626